Pentwater Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $82.8M | Buy |
|
|||||
|
2024
Q3 | $17.1M | Hold |
|
|||||
|
2024
Q2 | $17.4M | Hold |
|
|||||
|
2024
Q1 | $19.1M | Hold |
|
|||||
|
2023
Q4 | $20.1M | Hold |
|
|||||
|
2023
Q3 | $14.2M | Hold |
|
|||||
|
2023
Q2 | $10.5M | Hold |
|
|||||
|
2023
Q1 | $18.4M | Hold |
|
|||||
|
2022
Q4 | $31.7M | Hold |
|
|||||
|
2022
Q3 | $21.1M | Buy |
|
|||||
|
2022
Q2 | $12.8M | Hold |
|
|||||
|
2022
Q1 | $22.3M | Hold |
|
|||||
|
2021
Q4 | $33.8M | Hold |
|
|||||
|
2021
Q3 | $36.2M | Hold |
|
|||||
|
2021
Q2 | $49.8M | Hold |
|
|||||
|
2021
Q1 | $47.4M | Hold |
|
|||||
|
2020
Q4 | $54.5M | Buy |
|
|||||
|
2020
Q3 | $43.3M | Buy |
|